Crinetics Pharmaceuticals, Inc.
CRNXNASDAQHealthcareBiotechnology
As of Sep 2, 2026 close
- Market cap
- $8.97B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $32.30$85.01
- Volume (live)
- -
- Avg. volume (3M)
- 2.51M
Crinetics Pharmaceuticals (CRNX) Stock Price & Financial Analysis
Crinetics Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $84.95 - $84.95 |
|---|---|
| 52-Week High | $85.01 |
| 52-Week Low | $32.30 |
| Open | $84.95 |
| Average Volume (3M) | 2.51M |
| Revenue (TTM) | 42.16M |
|---|---|
| Net Income (TTM) | -501.61M |
| Free Cash Flow (TTM) | -425.18M |
| EPS (TTM) | −$5.04 |
| Profit Margin | -1189.88% |
| Operating Margin | -1302.52% |
| Return on Equity (ROE) | -42.08% |
| Debt to Equity | 0.03 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 8.97B |
|---|---|
| Shares Outstanding | 105.56M |
| Price to Sales (P/S) | 212.72 |
| Price to Book (P/B) | 7.52 |
| EV/EBITDA | -17.60 |
| 50-Day MA | $76.81 |
|---|---|
| 200-Day MA | $50.87 |
| 1-Year Change | +104.35% |
Source: Market prices and company fundamentals. Data as of Sep 2, 2026. Data sources and methodology
Crinetics Pharmaceuticals at a Glance
As of the Sep 2, 2026 close, Crinetics Pharmaceuticals (CRNX) has a market capitalization of $8.97B. The stock trades at 212.7× sales. Over the trailing twelve months it lost $501.61M on revenue of $42.16M and burned $425.18M of free cash flow. Revenue grew 2928.4% year over year.
As of its latest reported balance sheet, it holds $55.50M in cash and securities against $40.61M of debt, a net cash position of $14.89M.
Crinetics Pharmaceuticals does not currently pay a dividend.
The share price is up 104.4% over the past year. At $84.95 (the Sep 2, 2026 close) it sits near the top of its 52-week range of $32.30 to $85.01, above its 200-day moving average of $50.87.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Crinetics Pharmaceuticals
What is the current stock price for CRNX?
As of the Sep 2, 2026 close, CRNX stock trades at $84.95. The 52-week range is $32.30–$85.01, with a day range of $84.95–$84.95.
What is the P/E ratio for CRNX?
The P/E ratio (Price-to-Earnings) for CRNX is shown in the Key Statistics section. This valuation metric helps compare Crinetics Pharmaceuticals, Inc. to industry peers.
Does CRNX pay dividends?
Crinetics Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CRNX?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for CRNX is Buy.
What is the market cap of CRNX?
As of the Sep 2, 2026 close, Crinetics Pharmaceuticals's market capitalization is $8.97B, classifying it as a mid-cap company. Crinetics Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.